82.09
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CVS Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$83.29
Aprire:
$83.45
Volume 24 ore:
4.94M
Relative Volume:
0.62
Capitalizzazione di mercato:
$105.21B
Reddito:
$402.11B
Utile/perdita netta:
$1.73B
Rapporto P/E:
59.34
EPS:
1.3835
Flusso di cassa netto:
$7.81B
1 W Prestazione:
+5.32%
1M Prestazione:
+13.24%
6M Prestazione:
+5.04%
1 anno Prestazione:
+18.20%
Cvs Health Corp Stock (CVS) Company Profile
Nome
Cvs Health Corp
Settore
Industria
Telefono
(401) 765-1500
Indirizzo
ONE CVS DR., WOONSOCKET
Compare CVS vs UNH, ELV, CI, HUM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
CVS
Cvs Health Corp
|
82.09 | 105.21B | 402.11B | 1.73B | 7.81B | 1.3835 |
|
UNH
Unitedhealth Group Inc
|
368.78 | 334.93B | 449.71B | 12.81B | 19.67B | 13.24 |
|
ELV
Elevance Health Inc
|
372.68 | 80.93B | 200.42B | 5.24B | 6.45B | 23.50 |
|
CI
Cigna Group
|
282.90 | 74.83B | 278.13B | 6.74B | 7.66B | 23.60 |
|
HUM
Humana Inc
|
233.63 | 28.05B | 137.20B | 1.15B | 1.27B | 9.3439 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-12 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2025-10-14 | Iniziato | Goldman | Buy |
| 2025-08-18 | Aggiornamento | UBS | Neutral → Buy |
| 2025-08-14 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Aggiornamento | Edward Jones | Hold → Buy |
| 2024-12-03 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-05-30 | Iniziato | Robert W. Baird | Neutral |
| 2024-05-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-05-02 | Downgrade | UBS | Buy → Neutral |
| 2024-05-01 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2023-12-22 | Iniziato | HSBC Securities | Buy |
| 2023-09-19 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Downgrade | Edward Jones | Buy → Hold |
| 2023-05-26 | Iniziato | Piper Sandler | Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Ripresa | Morgan Stanley | Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-05-27 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Iniziato | Goldman | Buy |
| 2021-12-01 | Iniziato | Seaport Research Partners | Buy |
| 2021-05-19 | Iniziato | Wells Fargo | Equal Weight |
| 2021-03-17 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-01-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-09-17 | Iniziato | Piper Sandler | Overweight |
| 2020-07-01 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-05-14 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Ripresa | RBC Capital Mkts | Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Buy |
| 2019-06-05 | Aggiornamento | Standpoint Research | Hold → Buy |
| 2019-04-29 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Iniziato | Guggenheim | Buy |
| 2019-04-15 | Downgrade | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Reiterato | BofA/Merrill | Buy |
| 2019-03-13 | Iniziato | Bernstein | Outperform |
| 2019-02-20 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2018-12-18 | Iniziato | Barclays | Overweight |
| 2018-11-29 | Ripresa | Goldman | Neutral |
| 2018-11-28 | Iniziato | Evercore ISI | Outperform |
| 2018-10-26 | Ripresa | Wolfe Research | Peer Perform |
| 2018-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-02-27 | Ripresa | BofA/Merrill | Buy |
| 2018-02-13 | Reiterato | Citigroup | Neutral |
Mostra tutto
Cvs Health Corp Borsa (CVS) Ultime notizie
CVS and Google Cloud build AI health partner to cut care stress, costs - Stock Titan
US Bancorp DE Buys 13,440 Shares of CVS Health Corporation $CVS - MarketBeat
Hussman Strategic Advisors Inc. Makes New $3.33 Million Investment in CVS Health Corporation $CVS - MarketBeat
PFA Pension Forsikringsaktieselskab Takes $57.58 Million Position in CVS Health Corporation $CVS - MarketBeat
Strs Ohio Has $70.46 Million Stake in CVS Health Corporation $CVS - MarketBeat
Jim Cramer Makes Major Claim About CVS Corporation (CVS) - Insider Monkey
CVS Health Corp. stock underperforms Friday when compared to competitors - MarketWatch
Beyond medication: A whole person approach to lasting weight loss - CVS Health
CVS Health (CVS) Is Up 5.6% After Regulatory Tailwinds Boost Aetna And PBM Visibility – Has The Bull Case Changed? - Yahoo Finance
Jennison Associates LLC Has $110.78 Million Stock Holdings in CVS Health Corporation $CVS - MarketBeat
Danske Bank A S Has $73.68 Million Stock Position in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by GC Wealth Management RIA LLC - MarketBeat
The Boulder Group Arranges Sale of CVS Pharmacy in the Houston MSA - Barchart.com
Health Catalyst Appoints Steve Nelson, President of Aetna, to Its Board of Directors - Yahoo Finance
Cigna beats estimates, raises outlook on lower medical costs - Modern Healthcare
CVS Q1 Earnings Preview: Health Services Likely to Lead Performance - Yahoo Finance
W.G. Shaheen & Associates DBA Whitney & Co Takes Position in CVS Health Corporation $CVS - MarketBeat
Vest Financial LLC Buys 13,561 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health Corp. Stock (US1266501006): Q1 2026 Earnings Release Scheduled for Today - AD HOC NEWS
M&T Bank Corp Decreases Stock Position in CVS Health Corporation $CVS - MarketBeat
Vanguard Capital Management (NYSE: CVS) reports 95.6M shares, 7.51% stake - Stock Titan
CVS Health Corp. stock outperforms competitors on strong trading day - MarketWatch
CVS Health Corp Stock (CVS) Closed Up by 3.28% on Apr 29: Drivers Behind the Movement - TradingKey
CVS Sees Active Options Trading Amid Market Developments - GuruFocus
CVS Health Corp. Hits Day High with Strong 3.34% Intraday Surge - Markets Mojo
CVS Pharmacy Makes Cold & Cough Relief Easier With Delivery Straight to Your Door - ACCESS Newswire
CVS Health (CVS) to Release Earnings on Wednesday - MarketBeat
Wealthfront Advisers LLC Has $16.85 Million Position in CVS Health Corporation $CVS - MarketBeat
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know - Yahoo Finance
Mitsubishi UFJ Trust & Banking Corp Trims Stock Position in CVS Health Corporation $CVS - MarketBeat
CVS Health Corp (CVS) Stock Up 3.3% but GF Value Says Overvalued -- GF Score: 81/100 - GuruFocus
Is Eli Lilly Stock Undervalued at $870? 1 Top Wall Street Analyst Thinks So - The Motley Fool
CVS Health Corp Stock (CVS) Moved Up by 3.42% on Apr 28: A Full Analysis - TradingKey
CVS rises as investors focus on earnings outlook and Medicare Advantage tailwinds - Quiver Quantitative
CVS Health Stock Outlook: Is Wall Street Bullish or Bearish? - Yahoo Finance
CVS Health: What's Next in Treatment: Four Drugs That Could Change Care This Spring - ACCESS Newswire
Urban Wealth Management LLC Buys New Stake in CVS Health Corporation $CVS - MarketBeat
Sanctuary Advisors LLC Sells 14,711 Shares of CVS Health Corporation $CVS - MarketBeat
Comerica Bank Cuts Holdings in CVS Health Corporation $CVS - MarketBeat
Invesco Comstock Portfolio's CVS Health Corp(CVS) Holding History - GuruFocus
CVS Health Corp (CVS) Stock Price, Trades & News - GuruFocus
Operational, Regulatory and ESG Shifts Might Change The Case For Investing In CVS Health (CVS) - simplywall.st
CVS Health Wins Gold in Enterprise AI, and Silver in Customer Experience AI at 2026 Stevie® (American Business Awards®) for Enterprise Scale AI Innovation - ChartMill
Assessing CVS Health (CVS) Valuation After Recent Share Price Momentum And Mixed Signals - Yahoo Finance
Jim Cramer on CVS Health: “I Think It’s Only Going to Get Better as the Competition Disappears” - Insider Monkey
Vanguard Group Inc. Raises Stake in CVS Health Corporation $CVS - MarketBeat
Eli Lilly Stock Jumps Premarket On Dumping CVS Drug Plan After Wegovy Snub — Retail Calls It A Pushback Against PBM Power - MSN
CVS fights law that could force over 100 stores to close - thestreet.com
CVS Stock Quote Price and Forecast - CNN
CVS Health Corporation $CVS Stake Increased by Calamos Advisors LLC - MarketBeat
CVSE Bond Analysis — Key Metrics - TradingView
Cvs Health Corp Azioni (CVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):